Educators Improving their Performance without Burnout

 
Depending on the type of leadership role one takes in education, oftentimes, burnout is inevitable. According to Gallup research, K-12 educators report burnout the most, with four out of 10 indicating that burnout is a normal feeling for them. However, there are reasons for that and ways educators can reevaluate their performance in their leadership style. How does burnout happen with educators? And what are the ways they can improve their workplace performance without experiencing burnout?

In an episode of “DisruptED,” host Ron J Stefanski talked to Dr. Joe Hill, the founder of Higher Performance Group — a professional training and coaching company. The two discussed their concerns about burnout challenges facing educators. Having worked in various leadership roles as an educator, Hill is well-versed about the mental and physical obstacles educators face.

The stresses of a leadership role in education may come with challenges. Oftentimes, these drawbacks lead to many in those positions spending a short time in them. According to the Learning Policy Institute, principals in particular have a significant turnover rate and burnout\ is one of the contributing factors. But Hill added work-life balance doesn’t enter the equation, but rather a state of conditions.

“If you’re a school leader, you learn the lifestyle, you learn work and life—integration if you will—but there’s never balance. But there is certainly burnout and I think we’ve been seeing just heightened levels of that. I read a lot on what’s happening in the world of education with K-12 and higher ed, and they’re projecting nearly 40 percent leadership turnover over the next five years. Well, they’re having a hard time filling positions now—today,” said Hill.

Stefanski and Hill speak on performance without burnout …

● Balancing the desire for performance improvement and avoiding burnout

● The importance of educators forming communities that support and challenge them

● Emphasizing the necessity of value and worthiness in one’s work

“We all must get up in the morning to have something to look forward to that has any purpose to it, and it doesn’t matter if you’re checking into the office or going to volunteer down the street. Whatever the day consists of it should be worthy and purposeful—never accidental, always intentional,” said Hill.

Dr. Joe Hill is an educational leader, speaker, and founder of Higher Performance Group. He has over three decades of experience as an educator in being a teacher, principal, and a superintendent. He is a graduate of the University of North Dakota and St. Cloud State University. Hill has a forthcoming book being released this spring titled, “Leading from Peace,” which will focus on tips for leaders.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More